Social costs of obesity in the Czech Republic

J 2023

Social costs of obesity in the Czech Republic

LANDOVSKÁ, Petra and Martina KARBANOVÁ

Basic information

Original name

Social costs of obesity in the Czech Republic

Authors

LANDOVSKÁ, Petra (203 Czech Republic, guarantor) and Martina KARBANOVÁ (203 Czech Republic, belonging to the institution)

Edition

The European Journal of Health Economics, NEW YORK, SPRINGER, 2023, 1618-7598

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30304 Public and environmental health

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 4.400 in 2022

RIV identification code

RIV/00216224:14110/23:00130091

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1007/s10198-022-01545-8

UT WoS

000912818500001

Keywords in English

Cost-of-illness study; Czech Republic; Obesity; Social costs

Abstract

V originále

Increasing prevalence of obesity (BMI > 30) is a pressing public health issue in the Czech Republic as well as world-wide, affecting up to 2.1 billion people. Increasing trend in the prevalence of obesity in adults and children generates large social costs. The main aim of this study is to estimate both direct and indirect costs of obesity in the Czech Republic. Social costs of obesity are estimated using the cost-of-illness approach. Direct costs (healthcare utilization costs and costs of pharmacotherapy of 20 comorbidities) are estimated using the top-down approach, while indirect costs (absenteeism, presenteeism and premature mortality) are estimated using the human capital approach. In aggregate, the annual costs attributable to obesity in the Czech Republic in 2018 were 40.8 bn CZK (1.6 bn EUR, 0.8% GDP). Direct costs were 14.5 bn CZK (0.6 bn EUR) and accounted for 3.4% of Czech healthcare expenditures. The highest healthcare utilization costs were attributable to type II diabetes (20.6%), ischemic heart disease (18.8%) and osteoarthritis (16.7%). The largest indirect costs were attributable to premature mortality (10 bn CZK/0.39 bn EUR), absenteeism (9.2 bn CZK/0.36 bn EUR) and presenteeism (7.1 bn CZK/0.27 bn EUR). This article demonstrates that obesity is a serious problem with considerable costs. Several preventive interventions should be applied in order to decrease the prevalence of obesity and achieve cost savings.

Citovat

LANDOVSKÁ, Petra and Martina KARBANOVÁ. Social costs of obesity in the Czech Republic. The European Journal of Health Economics. NEW YORK: SPRINGER, 2023, vol. 24, No 8, p. 1321-1341. ISSN 1618-7598. Available from: https://dx.doi.org/10.1007/s10198-022-01545-8.

@article{2236216,
   author = {Landovská, Petra and Karbanová, Martina},
   article_location = {NEW YORK},
   article_number = {8},
   doi = {http://dx.doi.org/10.1007/s10198-022-01545-8},
   keywords = {Cost-of-illness study; Czech Republic; Obesity; Social costs},
   language = {eng},
   issn = {1618-7598},
   journal = {The European Journal of Health Economics},
   title = {Social costs of obesity in the Czech Republic},
   url = {https://link.springer.com/article/10.1007/s10198-022-01545-8},
   volume = {24},
   year = {2023}
}

TY  - JOUR
ID  - 2236216
AU  - Landovská, Petra - Karbanová, Martina
PY  - 2023
TI  - Social costs of obesity in the Czech Republic
JF  - The European Journal of Health Economics
VL  - 24
IS  - 8
SP  - 1321-1341
EP  - 1321-1341
PB  - SPRINGER
SN  - 16187598
KW  - Cost-of-illness study
KW  - Czech Republic
KW  - Obesity
KW  - Social costs
UR  - https://link.springer.com/article/10.1007/s10198-022-01545-8
N2  - Increasing prevalence of obesity (BMI > 30) is a pressing public health issue in the Czech Republic as well as world-wide, affecting up to 2.1 billion people. Increasing trend in the prevalence of obesity in adults and children generates large social costs. The main aim of this study is to estimate both direct and indirect costs of obesity in the Czech Republic. Social costs of obesity are estimated using the cost-of-illness approach. Direct costs (healthcare utilization costs and costs of pharmacotherapy of 20 comorbidities) are estimated using the top-down approach, while indirect costs (absenteeism, presenteeism and premature mortality) are estimated using the human capital approach. In aggregate, the annual costs attributable to obesity in the Czech Republic in 2018 were 40.8 bn CZK (1.6 bn EUR, 0.8% GDP). Direct costs were 14.5 bn CZK (0.6 bn EUR) and accounted for 3.4% of Czech healthcare expenditures. The highest healthcare utilization costs were attributable to type II diabetes (20.6%), ischemic heart disease (18.8%) and osteoarthritis (16.7%). The largest indirect costs were attributable to premature mortality (10 bn CZK/0.39 bn EUR), absenteeism (9.2 bn CZK/0.36 bn EUR) and presenteeism (7.1 bn CZK/0.27 bn EUR). This article demonstrates that obesity is a serious problem with considerable costs. Several preventive interventions should be applied in order to decrease the prevalence of obesity and achieve cost savings.
ER  -

LANDOVSKÁ, Petra and Martina KARBANOVÁ. Social costs of obesity in the Czech Republic. \textit{The European Journal of Health Economics}. NEW YORK: SPRINGER, 2023, vol.~24, No~8, p.~1321-1341. ISSN~1618-7598. Available from: https://dx.doi.org/10.1007/s10198-022-01545-8.

Detailed Information on Publication Record